Table 1. Affinities of fentanyl derivatives for the σ1R and μOR19.
No | Compound | Structural variation (cf.Chart 1) |
Affinity for |
|||||||
N-Sub | Rβ | R3 | R4-ax | Rpara | Rω-1 | Rω | σ1R | μOR from ref. 19 | ||
IC50 ± S.D. a | IC50 ± S.D. b | |||||||||
1 | Fentanyl | PhEth c | H | H | H | H | H | H | 4973 ± 2.3 | 1.23 ± 0.14 |
2 | Benzylfentanyl | Benz d | n/a e | H | H | H | H | H | 322.1 ± 1.9 | 489.7 ± 28.6 |
3 | Thenylfentanyl | ThMet f | n/a e | H | H | H | H | H | 1185 ± 2.0 | 245.5 ± 12.9 |
4 | β-Hydroxyfentanyl g | PhEth | OH | H | H | H | H | H | >10 000 h | 2.81 ± 0.13 |
5 | ω-Hydroxyfentanyl | PhEth | H | H | H | H | H | OH | >10 000 h | 97.7 ± 5.8 |
6 | ω-1-Hydroxyfentanyl g | PhEth | H | H | H | H | OH | H | >10 000 h | 489.0 ± 40.6 |
7 | p-Fluorofentanyl | PhEth | H | H | H | F | H | H | 495.3 ± 2.0 | 0.48 ± 0.03 |
8 | 3-Methylthiofentanyl g | ThEth i | H | Me | H | H | H | H | 465.0 ± 1.2 | 1.10 ± 0.10 |
9 | Sufentanil | ThEth | H | H | CH2OMe | H | H | H | 2077 ± 2.1 | 0.40 ± 0.03 |
10 | Norcarfentanil | H | n/a e | H | C(O)OMe | H | H | H | >10 000 h | 295.1 ± 1.3 |
11 | Remifentanil | C2H4C(O)OMe | n/a e | H | C(O)OMe | H | H | H | >10 000 h | 0.60 ± 0.08 |
12 | Alfentanil | TetrEth j | H | H | CH2OMe | H | H | H | >10 000 h | 38.9 ± 2.8 |
13 | SKF10047 (reference) | n/a e | n/a e | n/a e | n/a e | n/a e | n/a e | n/a e | 69.4 ± 2.1 | n/d k |
aHalf maximal inhibitory concentration in nM (± standard deviation) of [3H]-(+)-pentazocine specific binding; the results given are means from at least three experiments performed in duplicate; values recalculated to Ki are given in Table ESI-BIND-1.
bHalf maximal inhibitory concentration in nM ± standard deviation, taken from ref. 19.
c2-Phenyleth-1-yl.
dBenzyl.
eNot applicable.
f2-Thienylmethyl.
gTested as an enantiomeric or diastereoisomeric (8) mixture.
hThe values of [3H]-(+)-pentazocine displacement at 10 μM are given in Table ESI-BIND-1.
i2-Thien-2-ylethyl.
j2-(4-Ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazol-1-yl)ethyl.
kn/d – not determined.